UK opens first clinic devoted to prion disease:
This article was originally published in Clinica
The UK's first clinic devoted specifically to the diagnosis and treatment of prion diseases has been opened in London. The centre, headed by John Collinge of St Mary's Hospital, will work in close collaboration with the prion unit of the Medical Research Council, based at Imperial College London, which has launched a "major" research programme in this area. During his presentation of the centre at the World Congress of Neurology, held last week in London, Professor Collinge announced that the new clinic will offer a full range of diagnostic facilities including molecular genetic analysis and tonsil biopsy. Brain imaging and other tests will be provided to outpatients, with a neurological ward available for further investigations.
You may also be interested in...
Oxford University/AstraZeneca’s COVID-19 vaccine cuts the spread of the virus by 60%, apart from having 70% efficacy in reducing infections in vaccinated individuals. While that is good news for their Indian partner, Serum Institute, the 90% efficacy shown in a subset due to a dosing error causes a dilemma.
After announcing positive topline Phase II results for its Alzheimer’s candidate late last year, Korea's GemVax releases additional data showing significant improvement in secondary outcomes, further raising expectations for the novel peptide drug.
The US FDA’s decision to ask on device adverse event reports whether the device involved had been serviced by a third party could help the agency as well as device makers, says Ricki Chase, compliance practice director at Lachman Consultant Services.